For: | Rmali K, Puntis M, Jiang W. Prognostic values of tumor endothelial markers in patients with colorectal cancer. World J Gastroenterol 2005; 11(9): 1283-1286 [PMID: 15761964 DOI: 10.3748/wjg.v11.i9.1283] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v11/i9/1283.htm |
Number | Citing Articles |
1 |
Łukasz Pietrzyk. Biomarkers Discovery for Colorectal Cancer: A Review on Tumor Endothelial Markers as Perspective Candidates. Disease Markers 2016; 2016: 1 doi: 10.1155/2016/4912405
|
2 |
Elisa Pothin, Yosra Bedoui, Caroline Michault, Johanna Zemour, Emmanuel Chirpaz, Philippe Gasque, Mohamed Khettab, Franck Ah-Pine. CD248 Cleaved Form in Human Colorectal Cancer Stroma: Implications for Tumor Behavior and Prognosis. Laboratory Investigation 2025; 105(1): 102188 doi: 10.1016/j.labinv.2024.102188
|
3 |
Łukasz Pietrzyk, Paulina Wdowiak. Endosialin (TEM1) as a Diagnostic, Progression, and Prognostic Serum Marker for Patients With Colorectal Cancer—A Preliminary Study. Cancer Control 2020; 27(1) doi: 10.1177/1073274820903351
|
4 |
Daniel J. O’Shannessy, Hongyue Dai, Melissa Mitchell, Shane Huntsman, Stephen Brantley, David Fenstermacher, Damon R. Reed. Endosialin and Associated Protein Expression in Soft Tissue Sarcomas: A Potential Target for Anti-Endosialin Therapeutic Strategies. Sarcoma 2016; 2016: 1 doi: 10.1155/2016/5213628
|
5 |
Brian Tomkowicz, Katherine Rybinski, Brian Foley, Wolfgang Ebel, Brad Kline, Eric Routhier, Philip Sass, Nicholas C. Nicolaides, Luigi Grasso, Yuhong Zhou. Interaction of endosialin/TEM1 with extracellular matrix proteins mediates cell adhesion and migration. Proceedings of the National Academy of Sciences 2007; 104(46): 17965 doi: 10.1073/pnas.0705647104
|
6 |
Rebecca G. Bagley, Cecile Rouleau, Thia St. Martin, Paula Boutin, William Weber, Melanie Ruzek, Nakayuki Honma, Mariana Nacht, Srinivas Shankara, Shiro Kataoka, Isao Ishida, Bruce L. Roberts, Beverly A. Teicher. Human endothelial precursor cells express tumor endothelial marker 1/endosialin/CD248. Molecular Cancer Therapeutics 2008; 7(8): 2536 doi: 10.1158/1535-7163.MCT-08-0050
|
7 |
Axel Grothey, Jonathan R. Strosberg, Lindsay A. Renfro, Herbert I. Hurwitz, John L. Marshall, Howard Safran, Michael J. Guarino, George P. Kim, J.R. Hecht, Susan C. Weil, John Heyburn, Wenquan Wang, Charles Schweizer, Daniel J. O'Shannessy, Luis Alberto Diaz. A Randomized, Double-Blind, Placebo-Controlled Phase II Study of the Efficacy and Safety of Monotherapy Ontuxizumab (MORAb-004) Plus Best Supportive Care in Patients with Chemorefractory Metastatic Colorectal Cancer. Clinical Cancer Research 2018; 24(2): 316 doi: 10.1158/1078-0432.CCR-17-1558
|
8 |
K.A. Rmali, M.C.A. Puntis, W.G. Jiang. TEM-8 and tubule formation in endothelial cells, its potential role of its vW/TM domains. Biochemical and Biophysical Research Communications 2005; 334(1): 231 doi: 10.1016/j.bbrc.2005.06.085
|
9 |
Rebecca G. Bagley, Nakayuki Honma, William Weber, Paula Boutin, Cecile Rouleau, Srinivas Shankara, Shiro Kataoka, Isao Ishida, Bruce L. Roberts, Beverly A. Teicher. Endosialin/TEM 1/CD248 is a pericyte marker of embryonic and tumor neovascularization. Microvascular Research 2008; 76(3): 180 doi: 10.1016/j.mvr.2008.07.008
|
10 |
Daniel J. O’Shannessy, Michael F. Smith, Elizabeth B. Somers, Stephen M. Jackson, Earl Albone, Brian Tomkowicz, Xin Cheng, Young Park, Danielle Fernando, Andrew Milinichik, Brad Kline, Regan Fulton, Pankaj Oberoi, Nicholas C. Nicolaides. Novel antibody probes for the characterization of endosialin/TEM-1. Oncotarget 2016; 7(43): 69420 doi: 10.18632/oncotarget.11018
|
11 |
Lingyu Huang, Tongxiang Zou, Wenken Liang, Chune Mo, Jianfen Wei, Yecheng Deng, Minglin Ou. High-Throughput Sequencing Reveals That Rotundine Inhibits Colorectal Cancer by Regulating Prognosis-Related Genes. Journal of Personalized Medicine 2023; 13(3): 550 doi: 10.3390/jpm13030550
|
12 |
Franco Maria Venanzi, Massimiliano Petrini, Laura Fiammenghi, Elisabetta Bolli, Anna Maria Granato, Laura Ridolfi, Federica Gabrielli, Alessandra Barucca, Antonio Concetti, Ruggero Ridolfi, Angela Riccobon. Tumor endothelial marker 8 expression levels in dendritic cell-based cancer vaccines are related to clinical outcome. Cancer Immunology, Immunotherapy 2010; 59(1): 27 doi: 10.1007/s00262-009-0717-4
|
13 |
Richard L. Carpenter, Ivy Paw, Hu Zhu, Sherona Sirkisoon, Fei Xing, Kounosuke Watabe, Waldemar Debinski, Hui-Wen Lo. The gain-of-function GLI1 transcription factor TGLI1 enhances expression of VEGF-C and TEM7 to promote glioblastoma angiogenesis. Oncotarget 2015; 6(26): 22653 doi: 10.18632/oncotarget.4248
|
14 |
Yasuhiko Hamada, Akiko Eguchi, Kyosuke Tanaka, Masaki Katsurahara, Noriyuki Horiki, Misaki Nakamura, Mina Tenpaku, Motoh Iwasa, Masako Ichishi, Masatoshi Watanabe, Yoshiyuki Takei. Plexin domain containing protein 2 is more expressed within the invasive area of human colorectal cancer tissues. Human Cell 2021; 34(5): 1580 doi: 10.1007/s13577-021-00570-8
|
15 |
Zhihua Ruan, Zhao Yang, Yiqin Wang, Huiming Wang, Yongwen Chen, Xiaoyun Shang, Chenying Yang, Sheng Guo, Junfeng Han, Houjie Liang, Yuzhang Wu. DNA Vaccine Against Tumor Endothelial Marker 8 Inhibits Tumor Angiogenesis and Growth. Journal of Immunotherapy 2009; 32(5): 486 doi: 10.1097/CJI.0b013e3181a1d134
|
16 |
Quan Gong, Chao Liu, Cunde Wang, Li Zhuang, Lijuan Zhang, Xicai Wang. Effect of silencing TEM8 gene on proliferation, apoptosis, migration and invasion of XWLC‑05 lung cancer cells. Molecular Medicine Reports 2017; doi: 10.3892/mmr.2017.7959
|
17 |
K A Khan, A J Naylor, A Khan, P J Noy, M Mambretti, P Lodhia, J Athwal, A Korzystka, C D Buckley, B E Willcox, F Mohammed, R Bicknell. Multimerin-2 is a ligand for group 14 family C-type lectins CLEC14A, CD93 and CD248 spanning the endothelial pericyte interface. Oncogene 2017; 36(44): 6097 doi: 10.1038/onc.2017.214
|
18 |
Masahiro Yoshinaga, Yosuke Kitamura, Tomohito Chaen, Shinsaku Yamashita, Satoru Tsuruta, Teruaki Hisano, Yoichi Ikeda, Hironori Sakai, Kazuhiko Nakamura, Ryoichi Takayanagi, Yoichi Muto. The Simultaneous Expression of Peroxisome Proliferator-Activated Receptor Delta and Cyclooxygenase-2 May Enhance Angiogenesis and Tumor Venous Invasion in Tissues of Colorectal Cancers. Digestive Diseases and Sciences 2009; 54(5): 1108 doi: 10.1007/s10620-008-0465-x
|
19 |
Łukasz Pietrzyk, Paulina Wdowiak. Serum TEM5 and TEM7 concentrations correlate with clinicopathologic features and poor prognosis of colorectal cancer patients. Advances in Medical Sciences 2019; 64(2): 402 doi: 10.1016/j.advms.2019.07.001
|
20 |
Valentina Raia, Patrizia Mancuso, Francesco Bertolini. Tumor Angiogenesis. 2008; : 795 doi: 10.1007/978-3-540-33177-3_44
|
21 |
Kabir A. Khan, Jack L. McMurray, Fiyaz Mohammed, Roy Bicknell. C‐type lectin domain group 14 proteins in vascular biology, cancer and inflammation. The FEBS Journal 2019; 286(17): 3299 doi: 10.1111/febs.14985
|
22 |
Rebecca G Bagley. Endosialin: From Vascular Target to Biomarker for Human Sarcomas. Biomarkers in Medicine 2009; 3(5): 589 doi: 10.2217/bmm.09.54
|
23 |
P. Felicetti, M. Mennecozzi, A. Barucca, S. Montgomery, F. Orlandi, K. Manova, A.N. Houghton, P.D. Gregor, A. Concetti, F.M. Venanzi. Tumor endothelial marker 8 enhances tumor immunity in conjunction with immunization against differentiation Ag. Cytotherapy 2007; 9(1): 23 doi: 10.1080/14653240601048369
|
24 |
Manhong Xu, Xin Chen, Zihao Yu, Xiaorong Li. Receptors that bind to PEDF and their therapeutic roles in retinal diseases. Frontiers in Endocrinology 2023; 14 doi: 10.3389/fendo.2023.1116136
|
25 |
Ruoyu Cheng, Hélder A. Santos. Smart Nanoparticle‐Based Platforms for Regulating Tumor Microenvironment and Cancer Immunotherapy. Advanced Healthcare Materials 2023; 12(8) doi: 10.1002/adhm.202202063
|
26 |
K. A. Rmali, M. C. A. Puntis, W. G. Jiang. Tumour‐associated angiogenesis in human colorectal cancer. Colorectal Disease 2007; 9(1): 3 doi: 10.1111/j.1463-1318.2006.01089.x
|
27 |
LIN YE, PING-HUI SUN, ANDREW J. SANDERS, TRACEY A. MARTIN, JANE LANE, MALCOLM D. MASON, WEN G. JIANG. Therapeutic potential of capillary morphogenesis gene 2 extracellular vWA domain in tumour-related angiogenesis. International Journal of Oncology 2014; 45(4): 1565 doi: 10.3892/ijo.2014.2533
|
28 |
Stefano Ugel, John G. Facciponte, Francesco De Sanctis, Andrea Facciabene. Targeting tumor vasculature: expanding the potential of DNA cancer vaccines. Cancer Immunology, Immunotherapy 2015; 64(10): 1339 doi: 10.1007/s00262-015-1747-8
|
29 |
Zhi-Yong Zhang, Hong Zhang, Gunnar Adell, Xiao-Feng Sun. Endosialin expression in relation to clinicopathological and biological variables in rectal cancers with a Swedish clinical trial of preoperative radiotherapy. BMC Cancer 2011; 11(1) doi: 10.1186/1471-2407-11-89
|
30 |
Therapeutic Strategies in Cancer Biology and Pathology. 2013; : 217 doi: 10.1016/B978-0-12-416570-0.00043-3
|
31 |
Emmanuel E. Lagoudianakis, Agapi Kataki, Andreas Manouras, Nikolaos Memos, Artemisia Papadima, Anastasia Derventzi, George Zografos, Stefanos Papadopoulos, Vaggelogiannis Katergiannakis, Manoussos M. Konstadoulakis. Detection of Epithelial Cells by RT-PCR Targeting CEA, CK20, and TEM-8 in Colorectal Carcinoma Patients Using OncoQuick Density Gradient Centrifugation System. Journal of Surgical Research 2009; 155(2): 183 doi: 10.1016/j.jss.2007.10.013
|
32 |
Theo Crawford, Nicholas Fletcher, Margaret Veitch, Jazmina L. Gonzalez Cruz, Nicola Pett, Ian Brereton, James W. Wells, Mehdi Mobli, Yasvir Tesiram. Bacillus anthracis Protective Antigen Shows High Specificity for a UV Induced Mouse Model of Cutaneous Squamous Cell Carcinoma. Frontiers in Medicine 2019; 6 doi: 10.3389/fmed.2019.00022
|
33 |
Lars A. Akslen. Biomarkers of the Tumor Microenvironment. 2022; : 17 doi: 10.1007/978-3-030-98950-7_2
|
34 |
Ga‐Bin Park, Jee‐Yeong Jeong, Daejin Kim. Modified TLR‐mediated downregulation of miR‐125b‐5p enhances CD248 (endosialin)‐induced metastasis and drug resistance in colorectal cancer cells. Molecular Carcinogenesis 2020; 59(2): 154 doi: 10.1002/mc.23137
|
35 |
Minghua SUN, Hua LI, Jing LIU, Lirong NING, Dongjie ZHAO, Shiyong LIU. The relationship between TEM8 and early diagnosis and prognosis of lung cancer. Minerva Medica 2021; 112(3) doi: 10.23736/S0026-4806.20.06444-7
|
36 |
Ann-Marie Chacko, Chunsheng Li, Madhura Nayak, John L. Mikitsh, Jia Hu, Catherine Hou, Luigi Grasso, Nicholas C. Nicolaides, Vladimir R. Muzykantov, Chaitanya R. Divgi, George Coukos. Development of124I Immuno-PET Targeting Tumor Vascular TEM1/Endosialin. Journal of Nuclear Medicine 2014; 55(3): 500 doi: 10.2967/jnumed.113.121905
|
37 |
Daniel J. O’Shannessy, Elizabeth B. Somers, Lakshmi K. Chandrasekaran, Nicholas C. Nicolaides, Jennifer Bordeaux, Mark D. Gustavson. Influence of tumor microenvironment on prognosis in colorectal cancer: Tissue architecture-dependent signature of endosialin (TEM-1) and associated proteins. Oncotarget 2014; 5(12): 3983 doi: 10.18632/oncotarget.2108
|
38 |
Vladan Milosevic, Reidunn J. Edelmann, Johanna Hol Fosse, Arne Östman, Lars A. Akslen. Biomarkers of the Tumor Microenvironment. 2022; : 31 doi: 10.1007/978-3-030-98950-7_3
|
39 |
Lars A. Akslen. Biomarkers of the Tumor Microenvironment. 2017; : 55 doi: 10.1007/978-3-319-39147-2_3
|
40 |
Sara E.S. Lange, Alex Zheleznyak, Matthew Studer, Daniel J. O’Shannessy, Suzanne E. Lapi, Brian A. Van Tine. Development of 89Zr-Ontuxizumab for in vivo TEM-1/endosialin PET applications. Oncotarget 2016; 7(11): 13082 doi: 10.18632/oncotarget.7552
|
41 |
Michael S. Rogers, Lorna M. Cryan, Kaiane A. Habeshian, Lauren Bazinet, Thomas P. Caldwell, P. Christine Ackroyd, Kenneth A. Christensen, Rory Edward Morty. A FRET-Based High Throughput Screening Assay to Identify Inhibitors of Anthrax Protective Antigen Binding to Capillary Morphogenesis Gene 2 Protein. PLoS ONE 2012; 7(6): e39911 doi: 10.1371/journal.pone.0039911
|
42 |
Eiji Kiyohara, Nicholas Donovan, Ling Takeshima, Sharon Huang, James S. Wilmott, Richard A. Scolyer, Peter Jones, Elizabeth B. Somers, Daniel J. O’Shannessy, Dave S. B. Hoon. Endosialin Expression in Metastatic Melanoma Tumor Microenvironment Vasculature: Potential Therapeutic Implications. Cancer Microenvironment 2015; 8(2): 111 doi: 10.1007/s12307-015-0168-8
|
43 |
NICK A. BERSINGER, BRIGITTE SCHNEIDER, STEPHAN A. VORBURGER, SILKE JOHANN, DANIEL CANDINAS, MICHAEL D. MUELLER. Prognostic value of tumour endothelial markers in patients with endometrial cancer. Oncology Letters 2010; 1(1): 203 doi: 10.3892/ol_00000037
|
44 |
Toshihiko Doi, Takeshi Aramaki, Hirofumi Yasui, Kei Muro, Masafumi Ikeda, Takuji Okusaka, Yoshitaka Inaba, Kenya Nakai, Hiroki Ikezawa, Ryo Nakajima. A phase I study of ontuxizumab, a humanized monoclonal antibody targeting endosialin, in Japanese patients with solid tumors. Investigational New Drugs 2019; 37(5): 1061 doi: 10.1007/s10637-018-0713-7
|
45 |
Stephen A. Bustin, Reinhold Mueller. Real-time reverse transcription PCR and the detection of occult disease in colorectal cancer. Molecular Aspects of Medicine 2006; 27(2-3): 192 doi: 10.1016/j.mam.2005.12.002
|
46 |
Rebecca G. Bagley, Cecile Rouleau, William Weber, Khodadad Mehraein, Robert Smale, Maritza Curiel, Michelle Callahan, Andre Roy, Paula Boutin, Thia St. Martin, Mariana Nacht, Beverly A. Teicher. Tumor endothelial marker 7 (TEM-7): A novel target for antiangiogenic therapy. Microvascular Research 2011; 82(3): 253 doi: 10.1016/j.mvr.2011.09.004
|
47 |
Areck A. Ucuzian, Andrew A. Gassman, Andrea T. East, Howard P. Greisler. Molecular Mediators of Angiogenesis. Journal of Burn Care & Research 2010; 31(1): 158 doi: 10.1097/BCR.0b013e3181c7ed82
|
48 |
SOŇA KONTSEKOVÁ, ANNA OHRADANOVA REPIC, KATARÍNA POLČICOVÁ, PAULIINA TUOMAALA, JAROMÍR PASTOREK, SILVIA PASTOREKOVÁ, SEPPO PARKKILA, MONIKA BARÁTHOVÁ. Novel monoclonal antibodies specific for CTLD-SSC and sialomucin domains of endosialin, a mural cell marker of tumor vasculature. International Journal of Oncology 2012; 41(4): 1365 doi: 10.3892/ijo.2012.1566
|
49 |
William C. Aird. Molecular heterogeneity of tumor endothelium. Cell and Tissue Research 2009; 335(1): 271 doi: 10.1007/s00441-008-0672-y
|
50 |
Kasturi Ganguly, Uday Kishore, Taruna Madan. Handbook of Cancer and Immunology. 2023; : 1 doi: 10.1007/978-3-030-80962-1_94-1
|
51 |
Aizhi Zhao, Selene Nunez-Cruz, Chunsheng Li, George Coukos, Don L. Siegel, Nathalie Scholler. Rapid isolation of high-affinity human antibodies against the tumor vascular marker Endosialin/TEM1, using a paired yeast-display/secretory scFv library platform. Journal of Immunological Methods 2011; 363(2): 221 doi: 10.1016/j.jim.2010.09.001
|
52 |
Yiming Guan, Yuzhang Du, Guanzheng Wang, Hongquan Gou, Yilun Xue, Jingsong Xu, Enhao Li, David W. Chan, Di Wu, Peiqing Xu, Peihua Ni, Dakang Xu, Yiqun Hu. Overexpression of PLXDC2 in Stromal Cell-Associated M2 Macrophages Is Related to EMT and the Progression of Gastric Cancer. Frontiers in Cell and Developmental Biology 2021; 9 doi: 10.3389/fcell.2021.673295
|
53 |
Lin Ye, Ping-Hui Sun, Muhammad Faraz Arshad Malik, Malcolm D. Mason, Wen G. Jiang. Capillary morphogenesis gene 2 inhibits growth of breast cancer cells and is inversely correlated with the disease progression and prognosis. Journal of Cancer Research and Clinical Oncology 2014; 140(6): 957 doi: 10.1007/s00432-014-1650-2
|